CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations

Genes and Immunity

Volumn 13, Issue 5, 2012, Pages 431-436

  Eike, M C ^a   Skinningsrud, B ^a   Ronninger, M ^b   Stormyr, A ^a   Kvien, T K ^c   Joner, G ^d,e   Njolstad P R ^f,g   Forre O ^h   Flato B ^h   Alfredsson, L ^b   Padyukov, L ^b   Undlien, D E ^a   Lie, B A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DIAKONHJEMMET HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

arthritis; diabetes mellitus; geneticassociation studies; juvenile rheumatoid; MHC class II transactivator protein; rheumatoid; type 1

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II TRANSACTIVATOR GENE; MALE; NORWAY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCANDINAVIA; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; EPITOPES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; META-ANALYSIS AS TOPIC; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCANDINAVIA; TRANS-ACTIVATORS;

EID: 84864131679     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.11     Document Type: Article

References (33)

1. Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 2005; 5: 793-806. (Pubitemid 41400853)
2. Iikuni N, Ikari K, Momohara S, Tomatsu T, Hara M, Yamanaka H et al. MHC2TA is associated with rheumatoid arthritis in Japanese patients. Ann Rheum Dis 2007; 66: 274-275. (Pubitemid 46226072)
3. Orozco G, Robledo G, Linga Reddy MV, Garcia A, Pascual-Salcedo D, Balsa A et al. Study of the role of a functional polymorphism of MHC2TA in rheumatoid arthritis in three ethnically different populations. Rheumatology (Oxford) 2006; 45: 1442-1444. (Pubitemid 44605484)
4. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005; 37: 486-494. (Pubitemid 40617276)
5. Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Wolff AB et al. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab 2008; 93: 3310-3317.
6. Dieguez-Gonzalez R, Akar S, Calaza M, Gonzalez-Alvaro I, Fernandez-Gutierrez B, Lamas JR et al. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA. J Rheumatol 2009; 36: 1590-1595.
7. Eyre S, Bowes J, Spreckley K, Potter C, Ring S, Strachan D et al. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort. Arthritis Rheum 2006; 54: 3417-3412.
8. Harrison P, Pointon JJ, Farrar C, Harin A, Wordsworth BP. MHC2TA promoter polymorphism (-168G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford) 2007; 46: 409-411. (Pubitemid 46344650)
9. Newman WG, Zhang Q, Liu X, Walker E, Ternan H, Owen J et al. Rheumatoid arthritis association with the FCRL3-169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 2006; 54: 3820-3827. (Pubitemid 44955883)
10. Plant D, Barton A, Thomson W, Ke X, Eyre S, Hinks A et al. A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis. Ann Rheum Dis 2009; 68: 1373-1375.
11. Yazdani-Biuki B, Brickmann K, Wohlfahrt K, Mueller T, Marz W, Renner W et al. The MHC2TA-168A4G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients. Arthritis Res Ther 2006; 8: R97.
12. Akkad DA, Jagiello P, Szyld P, Goedde R, Wieczorek S, Gross WL et al. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups. Int J Immunogenet 2006; 33: 59-61.
13. O'Doherty C, Hawkins S, Rooney M, Vandenbroeck K. The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies. Tissue Antigens 2007; 70: 247-251. (Pubitemid 47106646)
14. Martinez A, Sanchez-Lopez M, Varade J, Mas A, Martin MC, de Las Heras V et al. Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis 2007; 66: 325-329. (Pubitemid 46579632)
15. Bronson PG, Criswell LA, Barcellos LF. The MHC2TA-168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association. Ann Rheum Dis 2008; 67: 933-936. (Pubitemid 351956653)
16. Martinez A, Perdigones N, Cenit MC, Espino L, Varade J, Lamas JR et al. Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. Ann Rheum Dis 2010; 69: 309-311.
17. Bronson PG, Ramsay PP, Seldin MF, Gregersen PK, Criswell LA, Barcellos LF. CIITA is not associated with risk of developing rheumatoid arthritis. Genes Immun 2011; 12: 235-238.
18. Skinningsrud B, Lie BA, Husebye ES, Kvien TK, Forre O, Flato B et al. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-CCP negative rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1471-1474.
19. McGovern DP, Gardet A, Torkvist L, Goyette P, Essers J, Taylor KD et al. Genomewide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 2010; 42: 332-337.
20. Libert F, Cochaux P, Beckman G, Samson M, Aksenova M, Cao A et al. The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet 1998; 7: 399-406. (Pubitemid 28120628)
21. van der Woude D, Lie BA, Lundstrom E, Balsa A, Feitsma AL, Houwing-Duistermaat JJ et al. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB11301: a meta-analysis of HLADRB1 associations with anti-citrullinated protein antibody-positive and anticitrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 2010; 62: 1236-1245.
22. Vang T, Miletic AV, Bottini N, Mustelin T. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007; 40: 453-461. (Pubitemid 47343357)
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324. (Pubitemid 18091653)
24. Kvien TK, Uhlig T. The Oslo experience with arthritis registries. Clin Exp Rheumatol 2003; 21(Suppl 31): S118-S122. (Pubitemid 37265600)
25. Syversen SW, Gaarder PI, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008; 67: 212-217. (Pubitemid 351183310)
26. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62: 835-841. (Pubitemid 37026493)
27. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38-46. (Pubitemid 43122184)
28. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-392. (Pubitemid 38160763)
29. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000; 355: 873-876.
30. Barker DL, Hansen MS, Faruqi AF, Giannola D, Irsula OR, Lasken RS et al. Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. Genome Res 2004; 14(5): 901-907. (Pubitemid 38660508)
31. Sayer DC, Whidborne R, De Santis D, Rozemuller EH, Christiansen FT, Tilanus MG. A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5. Tissue Antigens 2004; 63: 412-423. (Pubitemid 38648207)
32. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008; 57(4): 1084-1092.
33. The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.